Skip to content

Clinical trials

Atherosclerosis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Taiwan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20054
20071
20082
20091
20111
20122
20182
20191
20202
20211
20223
20243
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Active, not recruiting6
Unknown status6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital5
Amgen3
Novartis Pharmaceuticals3
AstraZeneca2
CSL Behring2
Concept Medical Inc.2
Eli Lilly and Company2
Far Eastern Memorial Hospital2
GlaxoSmithKline2
National Cheng-Kung University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis30
Cardiovascular Diseases8
Coronary Artery Disease5
Peripheral Arterial Disease4
Acute Coronary Syndrome3
Coronary Disease3
Diabetes Mellitus3
Heart Diseases3
Hypercholesterolemia2
Inflammation2

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.